Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pooled Analysis of Clinical Outcome of Patients with Chemorefractory Metastatic Colorectal Cancer Treated within Phase I/II Clinical Studies Based on Individual Biomarkers of Susceptibility: A Single-Institution Experience.
Sartore-Bianchi A, Amatu A, Bonazzina E, Stabile S, Giannetta L, Cerea G, Schiavetto I, Bencardino K, Funaioli C, Ricotta R, Cipani T, Schirru M, Gambi V, Palmeri L, Carlo-Stella G, Rusconi F, Di Bella S, Burrafato G, Cassingena A, Valtorta E, Lauricella C, Pazzi F, Gambaro A, Ghezzi S, Marrapese G, Tarenzi E, Veronese S, Truini M, Vanzulli A, Siena S. Sartore-Bianchi A, et al. Among authors: ricotta r. Target Oncol. 2017 Aug;12(4):525-533. doi: 10.1007/s11523-017-0505-6. Target Oncol. 2017. PMID: 28669023 Free PMC article. Clinical Trial.
Anti-EGFR monoclonal antibodies in the treatment of non-small cell lung cancer.
Sartore-Bianchi A, Cerea G, Schiavetto I, Giannetta L, Ricotta R, Maugeri MR, Moroni M, Marrapese G, Siena S. Sartore-Bianchi A, et al. Among authors: ricotta r. Ann Oncol. 2006 Mar;17 Suppl 2:ii49-51. doi: 10.1093/annonc/mdj922. Ann Oncol. 2006. PMID: 16608982 Free article. Review. No abstract available.
Cetuximab for treatment of metastatic colorectal cancer.
Cerea G, Ricotta R, Schiavetto I, Maugeri MR, Sartore-Bianchi A, Moroni M, Artale S, Siena S. Cerea G, et al. Among authors: ricotta r. Ann Oncol. 2006 Jun;17 Suppl 7:vii66-7. doi: 10.1093/annonc/mdl954. Ann Oncol. 2006. PMID: 16760297 Free article.
Magnetic resonance imaging as an early indicator of clinical outcome in patients with metastatic colorectal carcinoma treated with cetuximab or panitumumab.
Ricotta R, Vanzulli A, Moroni M, Colnago B, Oriani M, Nichelatti M, Sarnataro C, Venturini F, Di Bella S, Maiolani M, Giganti MO, Sartore-Bianchi A, Siena S. Ricotta R, et al. Clin Colorectal Cancer. 2013 Mar;12(1):45-53. doi: 10.1016/j.clcc.2012.07.001. Epub 2012 Oct 4. Clin Colorectal Cancer. 2013. PMID: 23041354
Regorafenib for metastatic colorectal cancer.
Ricotta R, Sartore-Bianchi A, Verrioli A, Vanzulli A, Siena S. Ricotta R, et al. Lancet. 2013 May 4;381(9877):1537. doi: 10.1016/S0140-6736(13)60976-9. Lancet. 2013. PMID: 23642696 No abstract available.
Regorafenib in metastatic colorectal cancer.
Sartore-Bianchi A, Zeppellini A, Amatu A, Ricotta R, Bencardino K, Siena S. Sartore-Bianchi A, et al. Among authors: ricotta r. Expert Rev Anticancer Ther. 2014 Mar;14(3):255-65. doi: 10.1586/14737140.2014.894887. Expert Rev Anticancer Ther. 2014. PMID: 24559322
53 results